<DOC>
	<DOCNO>NCT01798277</DOCNO>
	<brief_summary>This study aim compare antiarrhythmic drug therapy catheter ablation use SmartTOUCH catheter ( Biosense Webster Inc. ) treatment patient ventricular tachycardia coronary artery disease</brief_summary>
	<brief_title>Trial Comparing Ablation With Medical Therapy Patients With Ventricular Tachycardia</brief_title>
	<detailed_description>This multicenter , randomize prospective cohort study compare impact catheter ablation antiarrhythmic drug therapy treat patient sustain ventricular tachycardia ( VT ) coronary artery disease . Patients meet inclusion criterion exclusion criterion recruit study cohort . After baseline measurement take , patient randomize 2:1 fashion either undergo radiofrequency catheter ablation receive antiarrhythmic drug therapy ( amiodarone sotalol ) . The in-clinic appointment include : enrollment , baseline , intervention , follow-up every three month one year post-ablation . At follow-up visit , electrogram ( ECG ) Holter monitoring test perform measure episode ventricular tachyarrhythmia . Furthermore , interrogation patient 's implantable cardioverter defibrillator ( ICD ) perform follow-up visit detect episode ventricular tachyarrhythmia require antitachycardia pace ( ATP ) shock .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<mesh_term>Amiodarone</mesh_term>
	<mesh_term>Sotalol</mesh_term>
	<mesh_term>Anti-Arrhythmia Agents</mesh_term>
	<criteria>Sustained monomorphic VT ( &gt; 30 second , require appropriate ICD therapy patient ICDs ) Documented ischemic heart disease option revascularization Ability willingness give write informed consent participate trial VT set metabolic abnormality acute ischemia coronary lesion suitable revascularization identify . Acute ischemia eligibility revascularization Significant peripheral arterial disease prevent transvascular access leave ventricle . Patients arrhythmogenic right ventricular cardiomyopathy ( ARVC ) , hypertrophic cardiomyopathy , Brugada syndrome , Long QT syndrome , dilate cardiomyopathy Prior long term therapy Class III Class IC antiarrhythmic agent ( longer 2 week ) Patient may potentially pregnant Patient mechanical heart valve Myocardial infarction within past 90 day Stroke within past 90 day New York Heart Association ( NYHA ) functional class IV Hemorrhagic manifestation , bleed diathesis , impairment hemostasis Lesions risk clinically significant bleeding ( e.g. , extensive cerebral infarction within last 6 month , active peptic ulcer disease recent bleeding ) Prior VT ablation procedure Contraindication allergy contrast medium , routine procedural medication catheter material Contraindications interventional procedure Life expectancy le 6 month Incessant multiple episode VT require immediate therapy medication ablation Untreated hypothyroidism hyperthyroidism ( euthyroid thyroid hrt acceptable ) Current enrolment another investigational drug device study There condition present investigator feel would problematic would restrict limit participation patient entire study period Absolute contraindication use heparin warfarin Documented intraarterial thrombus , ventricular thrombus , ( less 6 month detection thrombus ) , tumor abnormality precludes catheter introduction</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Keywords provide Newmarket Electrophysiology Research Group Inc :</keyword>
	<keyword>Ventricular tachycardia</keyword>
	<keyword>Ventricular tachyarrhythmia</keyword>
	<keyword>Ablation</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>Ischemic heart disease</keyword>
	<keyword>Amiodarone</keyword>
	<keyword>Sotalol</keyword>
	<keyword>Anti-Arrhythmia Agents</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>Pharmacologic Actions</keyword>
	<keyword>Additional relevant MeSH term :</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Arrhythmias , Cardiac</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Pathologic Processes</keyword>
	<keyword>Catheter Ablation , Radiofrequency</keyword>
</DOC>